Eton Pharmaceuticals, Inc. (ETON) Institutional Ownership & Insider Trading
165 institutions reported holding Eton Pharmaceuticals, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 24 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ETONEton Pharmaceuticals, Inc.Follow ETON — free
—
Price chart with a free account
- Market cap
- 1.4B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters165 institutions held 74.0% of the shares. Across filers that reported both quarters, shares held changed +17.9%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 165 | 21 | +17.9% | 56 | 50 | 33 | 3 |
| Mar 26 | 116 | 18 | +9.5% | 32 | 24 | 30 | 14 |
| Dec 25 | 102 | 16 | -11.8% | 27 | 20 | 33 | 17 |
| Sep 25 | 101 | 18 | +8.8% | 25 | 24 | 26 | 10 |
| Jun 25 | 84 | 17 | +17.2% | 34 | 24 | 18 | 25 |
| Mar 25 | 85 | 14 | +7.5% | 28 | 26 | 21 | 11 |
| Dec 24 | 70 | 13 | +33.4% | 27 | 24 | 10 | 3 |
| Sep 24 | 47 | 10 | +1.5% | 10 | 11 | 9 | 9 |
Eton Pharmaceuticals, Inc. — questions
- Who owns Eton Pharmaceuticals, Inc. stock?
- 165 institutions reported Eton Pharmaceuticals, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: Opaleye Management Inc. (10.0%), Nantahala Capital Management, LLC (8.2%), EcoR1 Capital, LLC (7.6%).
- Are Eton Pharmaceuticals, Inc. insiders buying or selling?
- 24 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from Eton Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.